Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danbi Lee

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Digestive Diseases and Sciences|January 31, 2013
Predisposing factors of hepatocellular carcinoma recurrence following complete remission in response to transarterial chemoembolizationYoung-Joo Jin, Young-Hwa Chung, Jeong A Kim, et al.
Hepatology Communications|July 7, 2020
Regorafenib Versus Nivolumab After Sorafenib Failure: Real-World Data in Patients With Hepatocellular CarcinomaWon-Mook Choi, Jonggi Choi, Danbi Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinomaSae Hwan Lee, Young-Hwa Chung, Jeong A Kim, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 7, 2015
A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular CarcinomaSeohyun Lee, Seungbong Han, Ju Hyun Shim, et al.
Journal of Gastroenterology and Hepatology|July 23, 2011
rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapyYoon-Seon Lee, Young-Hwa Chung, Jeong A Kim, et al.
Plos One|March 16, 2018
Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control studyJihyun An, Jong Woo Kim, Ju Hyun Shim, et al.
The Korean Journal of Hepatology|September 29, 2009
Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolizationSung Hoon Kim, Young Hwa Chung, Soo Hyun Yang, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 24, 2015
Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysisGi-Ae Kim, Ju Hyun Shim, Sang Min Yoon, et al.
Hepatology Communications|January 2, 2026
Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocolHyo Jung Park, Jonggi Choi, Dong Wook Kim, et al.
Oncology|March 23, 2025
Atezolizumab plus Bevacizumab Is Associated with Favorable Overall Survival over Lenvatinib in Patients with Unresectable Hepatocellular CarcinomaHyung-Don Kim, Young-Gyu Park, Hyeyeon Hong, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Digestive Diseases and Sciences|January 31, 2013
Predisposing factors of hepatocellular carcinoma recurrence following complete remission in response to transarterial chemoembolizationYoung-Joo Jin, Young-Hwa Chung, Jeong A Kim, et al.
Hepatology Communications|July 7, 2020
Regorafenib Versus Nivolumab After Sorafenib Failure: Real-World Data in Patients With Hepatocellular CarcinomaWon-Mook Choi, Jonggi Choi, Danbi Lee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Single nucleotide polymorphisms associated with metastatic tumour antigen 1 overexpression in patients with hepatocellular carcinomaSae Hwan Lee, Young-Hwa Chung, Jeong A Kim, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 7, 2015
A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular CarcinomaSeohyun Lee, Seungbong Han, Ju Hyun Shim, et al.
Journal of Gastroenterology and Hepatology|July 23, 2011
rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapyYoon-Seon Lee, Young-Hwa Chung, Jeong A Kim, et al.
Plos One|March 16, 2018
Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control studyJihyun An, Jong Woo Kim, Ju Hyun Shim, et al.
The Korean Journal of Hepatology|September 29, 2009
Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolizationSung Hoon Kim, Young Hwa Chung, Soo Hyun Yang, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 24, 2015
Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysisGi-Ae Kim, Ju Hyun Shim, Sang Min Yoon, et al.
Hepatology Communications|January 2, 2026
Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocolHyo Jung Park, Jonggi Choi, Dong Wook Kim, et al.
Oncology|March 23, 2025
Atezolizumab plus Bevacizumab Is Associated with Favorable Overall Survival over Lenvatinib in Patients with Unresectable Hepatocellular CarcinomaHyung-Don Kim, Young-Gyu Park, Hyeyeon Hong, et al.
Pageof 19